Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2018 06:00 ET | Source: Global Market Insights, Inc

Genetic Testing Market worth over $22 Billion By 2024: Global Market Insights, Inc.

Sellbyville, Delaware, June 05, 2018 (GLOBE NEWSWIRE) -- World Genetic Testing Market is projected to surpass USD 22 billion by 2024; according to a new research report by Global Market Insights....
June 05, 2018 05:00 ET | Source: Global Market Insights, Inc

Prenatal and New-born Genetic Testing Market worth over $7 Billion by 2024: Global Market Insights, Inc.

Sellbyville, Delaware, June 05, 2018 (GLOBE NEWSWIRE) -- Global Prenatal and New-born Genetic Testing Market is poised to surpass USD 7 billion by 2024; according to a new research report by...
June 04, 2018 09:30 ET | Source: DNA Oyj

DNA Oyj: Johdon liiketoimet: Pekka Väisänen

DNA OYJ JOHDON LIIKETOIMET 4.6.2018 KLO 16.30 DNA Oyj:n kuluttajaliiketoiminnan johtaja Pekka Väisänen on tehnyt markkinoiden väärinkäyttöasetuksen (MAR) edellyttämän ilmoituksen liiketoimesta DNA...
June 04, 2018 09:30 ET | Source: DNA Oyj

DNA Plc: Managers' transactions: Pekka Väisänen

DNA PLC MANAGERS' TRANSACTIONS 4 June, 2018 at 16:30 EEST DNA has received a notification from Pekka Väisänen, Senior Vice President, Consumer Business and member of the Executive team, of a...
June 04, 2018 09:00 ET | Source: Credence Research Inc.

Anti-Counterfeit Packaging Technologies Market Worth Will Be US$ 357.9 Billion By 2026: Credence Research

SAN JOSE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- According to a new market research report published by Credence Research “Anti-Counterfeit Packaging Technologies Market (Type – Coding and...
June 04, 2018 09:00 ET | Source: Oncobiologics, Inc.

Stelis Biopharma and Oncobiologics to Unveil Bio2Source CDMO Offering at BIO 2018

CRANBURY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Stelis Biopharma and Oncobiologics, Inc. (NASDAQ:ONS) today announced that they will unveil a new contract development and manufacturing (“CDMO”)...
June 04, 2018 08:00 ET | Source: Versartis, Inc.

Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing Innovative Oncology Therapeutics

- Tolerability and proof-of-mechanism for lead candidate AVB-S6-500, a novel GAS6-AXL pathway inhibitor, established in ongoing Phase 1 clinical study - Multi-study clinical development program in...
June 04, 2018 08:00 ET | Source: Rexahn Pharmaceuticals

Rexahn Pharmaceuticals Announces Presentations at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Phase 2a Trial of RX-5902 Advances to Stage 2 Based on Encouraging Progression Free Survival and Evidence of Tumor Shrinkage Observed in Heavily Pre-treated Metastatic Triple Negative Breast Cancer...
June 04, 2018 07:04 ET | Source: Aptose Biosciences, Inc.

Aptose Announces Two Publications of Preclinical Data Elucidating the Anticancer Mechanism of Action of APTO-253

Identification of APTO-253 target leading to inhibition of MYC expression in AML and hypersensitivity of cancer cells with BRCA1/2 deficiencies SAN DIEGO and TORONTO, June 04, 2018 (GLOBE NEWSWIRE)...
June 04, 2018 06:00 ET | Source: NanoString Technologies, Inc.

NanoString Announces Collaboration with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery

SEATTLE, June 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...